Aspects of functional constipation : a trial of an opioid antagonist as a treatment and an investigation of the colonic microbiota associated with the illness
INTRODUCTION Functional constipation (FC) is a common condition which affects patients’ quality of life (QoL), is of uncertain pathophysiology, and is poorly treated. The aims of this research were to conduct a randomised, placebo-controlled trial investigating an opiate antagonist (Naloxone - Nalco...
Main Author: | Bignell, Mark |
---|---|
Published: |
University of East Anglia
2014
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.665957 |
Similar Items
-
Aspects of colonic motility in idiopathic slow transit constipation
by: MacDonald, Angus
Published: (1995) -
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
by: Pergolizzi Jr JV, et al.
Published: (2017-01-01) -
Methylnaltrexone in the treatment of opioid-induced constipation
by: Beverley Greenwood-Van Meerveld, et al.
Published: (2008-12-01) -
The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
by: Pergolizzi JV Jr, et al.
Published: (2020-03-01) -
Opioid-Induced Constipation in Advanced Illness: Safety and Efficacy of Methylnaltrexone Bromide
by: S. Bader, et al.
Published: (2011-01-01)